LEADER 01786nam  2200433   450 
001 9910717232903321
005 20221025111320.0
035   $a(CKB)4100000006098620
035   $a(NjHacI)994100000006098620
035   $a(OCoLC)1049788631
035   $a(EXLCZ)994100000006098620
100   $a20221025d2017      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aComparing antithrombotic strategies after bioprosthetic aortic valve replacement $ea systematic review /$fJoel Papak [and others]
210  1$aWashington, DC :$cDepartment of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service,$d2017.
210  4$dİ2017
215   $a1 online resource (iv, 91 pages) $cillustrations
225 1 $aEvidence-based synthesis program (Series)
300   $a"December 2017."
320   $aIncludes bibliographical references.
410  0$aEvidence-based synthesis program (Series)
517   $aComparing antithrombotic strategies after bioprosthetic aortic valve replacement
606   $aFibrinolytic agents
615  0$aFibrinolytic agents.
676   $a174.2
700   $aPapak$b Joel$01353411
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
712 02$aPortland VA Medical Center.$bEvidence-based Synthesis Program Center.
712 02$aQuality Enhancement Research Initiative (U.S.)
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910717232903321
996   $aComparing antithrombotic strategies after bioprosthetic aortic valve replacement$93253933
997   $aUNINA